Top therapeutic areas of sponsored research conducted in 2024 are in Oncology/Hemato-Onco, ID and Cardiology
Phase III form the largest type of sponsored interventional research, followed by Phase II studies.
AstraZeneca, Merck Sharp & Dohme and Novartis were the top 3 Sponsors in 2024.
IQVIA, PAREXEL and ICON were the top 3 CROs in 2024.